Virtual ESC Congress 2020 through Tuesday
A number of Duke Heart team members are scheduled speakers during the European Society of Cardiology’s 2020 Congress, being held virtually. The event began this weekend and runs through Tuesday. Speakers include Sana Al-Khatib, Renato Lopes, Neha Pagidipati, Manesh Patel, Adrian Hernandez, Ann Marie Navar, Anthony Carnicelli and Sean Pokorney. Registration this year is free and all presentations will be available in the ESC Congress platform with access to slides, videos and abstracts until September 30.
Some of the news items coming out of ESC include Renato Lopes presenting on the ISCHEMIA trial (title: Initial Invasive versus Conservative Management for Stable Ischemic Heart Disease with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial, which was presented yesterday.
Also, some good news for patients with hypertrophic cardiomyopathy – information from the EXPLORER-HCM clinical trial were presented yesterday as a late breaker. Results were presented by lead investigator Iacopo Olivotto, MD, of Careggi University Hospital, Florence, Italy. The findings showed the drug, Mavacamten, improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy.
“The findings represent a breakthrough, first-in-class drug for patients with HCM,” said Andrew Wang, director of the Duke Hypertrophic Cardiomyopathy Clinic. “Duke had major roles in enrollment as well on as the Steering Committee, which included Matt Roe, Michael Felker and myself, as well as members of the DCRI stats team.”
Duke’s involvement with the trial goes back to 2014, when we had several of the first patients in the world with HCM receiving the drug. This could be the first drug available specifically indicated for the treatment of obstructive HCM – currently all other drugs in use are being used off-label.
Also released at ESC so far, 2020 ESC guidelines for the management of adult congenital heart disease (https://bit.ly/2Gc6Dyd); 2020 ESC Guidelines on sport cardiology and exercise in patients with cardiovascular disease (https://bit.ly/3b4tqau), 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation (https://bit.ly/31M9QNj), as well as the 2020 ESC Clinical Practice Guidelines for the management of non-ST-segment elevation acute coronary syndromes (NSTE-ACS) (https://bit.ly/3joftXC)
Coming up on the schedule over the next two days: Hernandez, Navar, Carnicelli and Pokorney!
Bed Expansion Coming for Heart Services
As many of you know, we have been working over the last several months to improve our hospital access for our heart patients in the community. The recent COVID-19 pandemic has only exacerbated the need for more dedicated heart space. The requirements have included both needs for stepdown beds and intensive care unit beds and space. Additionally, as we look to our future, we have been looking to determine the best way to build innovative care spaces that improve the quality of care, education, and provide a way to inform future practice.
Recently, with moves of the Neuro ICU and Neuro stepdown units to the new bed tower, we have had an opportunity to pitch our vision for more beds and coordinated services to the health system. These chances for additional beds do not come up very often, and as a cardiology group and service line, we felt it was essential to our long-term success. We have been fortunate that our request has been supported by Duke Hospital leadership as part of the overall plan for growth of Heart Services at Duke Health.
Over the last several weeks we have engaged our CICU faculty and leaders to review the possibility of moving the CICU to 7 East (24 beds), next to 7 West (CTICU). We would look to keep 7700 to improve our Stepdown/intermediate bed capacity (17 beds; net increase of 5 beds), help move some of our short stay to 7200, and improve our CDU footprint for work in 7200. No spaces are perfect for each patient care group, but individually and in total we see this as opportunities to improve our patient care and experience.
In order to move our care to the future space with input from our faculty, fellows and staff, a team led by our CICU leadership and to include fellows, CICU faculty, other divisional vice-chiefs and faculty section leaders, and nursing leadership will be meeting to review and map out steps of transition and consider coverage models. We are committed to ensuring we have enough staffing and resources before increasing bed capacity even after the move.
This growth and need is a testament to all of you, your expertise, your dedication, and the care we provide to our patients as a team. We are fortunate to have more patients wanting to come to Duke and these moves allow us to better fulfill our mission, vision and values.
Thank you for your patience as we work to optimize patient access at DUH and Duke Heart. Please watch for local meetings and zooms for further updates and opportunities to discuss how we make this effort a complete success for everyone.
Shout-out: Matt Carlisle
We received a shout-out this week for Matt Carlisle, first year cardiology fellow this week. Sunil Rao had this to say, “Just wanted to drop you a note that Matt Carlisle did a great job in VA clinic this week. He did several days covering for his colleagues who were taking the Medicine boards. His presentations were terrific and his management plans were spot on.” Hat tip to Anna Lisa Crowley for the share, who added that Matt is terrific and conscientious. Carlisle responded by sharing that “The entire class has covered each other this month for boards, have a great group to work with!” Great job, Matt!!! We have amazing fellows in our program – we’re glad to have each and every one of you here at Duke Heart and we appreciate all that you’re doing!
Good Catch, Oxendine!
One of our amazing team members from 7100/7200 has received a Good Catch award. Way to go, Melissa Oxendine, (RN CNII)!! She noticed that valacyclovir po was still active in eMAR when patient was placed NPO and IV form was ordered. Many thanks to Laura Dickerson and Antoniette Embler for alerting us! Keep up the great work!
Upcoming Opportunities/Save the Date:
Sept. 4: Weight Management Case Conference. Noon- 1 p.m. via Zoom
Presented by weight management experts from:
- Duke Diet and Fitness Center
- Duke Metabolic and Weight Loss Surgery
- Duke Healthy Lifestyles Clinic
- Duke Keto Medicine Clinic
- Duke Primary Care and
- Duke Cardiology, Duke Cardiometabolic Prevention Program & Duke Heart
Join Zoom Meeting
https://duke.zoom.us/j/96782978813?pwd=aVVURVRnNFVmVlZrTlRqalg1eC96Zz09
Meeting ID: 967 8297 8813
Passcode: 293321
DIHI: Request for Applications (RFA 2021 Innovation Projects)
Duke Institute for Health Innovation (DIHI) announces the next emerging ideas and funding cycle for innovative ideas and projects. Proposed projects should address actual and important problems encountered by care providers, patients and their loved ones and represent urgent health challenges nationally. For the upcoming funding cycle, DIHI is specifically interested in innovations in areas that: (a) Improve value of care through novel strategies, (b) Create digital solutions for care and monitoring (home monitoring, wearables etc.), (c) Advance health equity, (d) Enhance provider and staff experience and well-being, (e) Accelerate population health solutions and strategies, and (f) Enhance patient engagement and experience.
Please visit https://dihi.org/events/dihi-rfa for additional information and instructions. The deadline for submitting applications is midnight October 9, 2020. All proposals are required to have a Duke Health operational lead as a cosponsor to be accepted for review. If the DIHI team can be of any assistance in the formulation of ideas or connections, please contact Suresh Balu. We look forward to your innovative solutions.
Translating Duke Health Cardiovascular Disease Initiative – COVID-19Duke Health is excited to announce a request for innovative pilot project proposals for high risk/high impact research in the area of the heart disease and COVID-19. The intent of this RFP is to support one to four pilot projects that help us better understand how to prevent the transition from cardiovascular health to disease and/or facilitate the return to health. We are especially interested in: (1) proposals that span multiple dimensions from basic to clinical to populations, (2) proposals that build new collaborations and/or new teams, and (3) proposals that might lead to extended productive and NIH-funded collaborations.
Translating Duke Health (TDH) plans to fund zero to four awards in response to this request for proposals. One of the awards will be in concert with the Design Health program – a program in which learners work with engineering to solve clinical problems. For the joint award, there is an additional goal to facilitate the formation of a new collaboration between faculty in the Schools of Medicine and Engineering. This request for proposals is not meant to provide bridge funding or be supplementary funding for existing projects.
The funding amount is up to $100,000 per award. Some faculty effort may be included (not to exceed 20% of the budget). The proposed research should be appropriate to the budget and must be accomplished within one year. Proposals have a 4-page limit.
Applications are due September 21st 2020. Click here to see the full RFP and to find additional details about eligibility, funding, proposal requirements, selection process and review criteria. Questions should be directed to translatingdukehealth@duke.edu.
Translating Duke Health is one of the signature programs animating Advancing Health Together, our Duke Health Strategic Planning Framework. Translating Duke Health is a multiyear, multidisciplinary program to capitalize on our collective strengths in research, clinical care and population health to address major health challenges. Additional information about Translating Duke Health is available at www.translatingdukehealth.org.
2020 Triangle Heart Walk Going “Digital”; Will Be Held Oct. 10
Sign up is open for the 2020 Triangle Heart Walk which is going virtual! Instead, the American Heart 
Association is planning for a nation-wide digital experience across several weeks leading up to the main event on October 10. You can register at: www.TriangleHeartWalk.org/Duke. Message from Tom Owens: https://duh.dh.duke.edu/president-notes/triangle-heart-walk-goes-virtual-2020 (NET ID required)
COVID-19 Updates:
All the latest official DUHS information regarding coronavirus/COVID-19 response at the following locations:
Have news to share?
If you have news to share with the Pulse readership, please contact Tracey Koepke, director of communications for Duke Heart at tracey.koepke@duke.edu. We would love to hear about your latest accomplishments, professional news, cool happenings, and any events or opportunities that may be of interest to our Duke Heart family. Please call with any questions: 919-681-2868. Feedback on Pulse is welcome and encouraged.
Duke Heart in the News:
August 23 — Neha Pagidipati
Healio/Endocrinology
SGLT2s, GLP-1s benefit both sexes despite greater CV risks among women with diabetes
https://www.healio.com/news/endocrinology/20200823/sglt2s-glp1s-benefit-both-sexes-despite-greater-cv-risks-among-women-with-diabetes
August 25 — Duke University Hospital
Becker’s Hospital Review
Top 10 Hospitals for Consumer Loyalty
https://www.beckershospitalreview.com/rankings-and-ratings/top-10-hospitals-for-consumer-loyalty-2.html
August 29 — Jonathan Piccini
MedPage Today
Impressive Results With Early-Rhythm Control in AFib
https://www.medpagetoday.com/meetingcoverage/esc/88349
August 30 — Jonathan Piccini
Healio/Cardiology
Cryoballoon ablation may be better first-line treatment vs. drug therapy in paroxysmal AF
https://bit.ly/2Gd3Uo4
August 30 — Renato Lopes
Healio/Cardiac-Vascular Intervention
Invasive approach to stable ischemic heart disease may benefit in HF, LV dysfunction
https://www.healio.com/news/cardiac-vascular-intervention/20200830/invasive-approach-to-stable-ischemic-heart-disease-may-benefit-in-hf-lv-dysfunction
Recent Comments